Allianz Biotech Private Limited
About Allianz Biotech Private Limited
Data last updated:
Allianz Biotech Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 September 2003.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2003PTC051535.
The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹4.7 Lakh. It was led by directors Bhawarlal Gour and Radha Kishan Jhaver.
Its last annual general meeting (AGM) was held on 14 August 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Unit No.9B 3rd Floor R A Building 72 Marshalls Road Egmore, Chennai, Tamil Nadu, India – 600008.
As per the financials filed for FY 2024, the company reported a revenue of ₹71,198, a growth of 82% compared to the previous year. For the same year it recorded a net profit of ₹33,780 (net margin 47.4%) and EBITDA of ₹46,240 (EBITDA margin 64.9%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years.
Company details
Contact details
Allianz Biotech Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressUnit No.9B 3rd Floor R A Building 72 Marshalls Road Egmore, Chennai, Tamil Nadu, India – 600008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Allianz Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Allianz Biotech Private Limited
FY 2024 filings availableAllianz Biotech Private Limited reported revenue of ₹71,198 (up 82% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 82% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 38%. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹46,240 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33,780 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 64.9% | ||||
| Net Profit Margin | 47.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Allianz Biotech Private Limited, buy the company report.
Board of directors of Allianz Biotech Private Limited
Allianz Biotech has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhawarlal Gour | Director | 29 Jun 2018 | 8 Years 4 Months | As last reported |
| Radha Kishan Jhaver | Director | 20 Sep 2010 | 16 Years 1 Months | As last reported |
Peer comparison
Allianz Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Open Source Pharma Foundation | ₹76,099 (FY 2025) | -58.0% | Bangalore, Karnataka, India | |||
| Albay Pharmaceuticals Private Limited | ₹74,806 (FY 2023) | 19032.0% | Delhi, India | |||
| Cronus Research Labs Private Limited | ₹74,430 (FY 2025) | -94.0% | Hyderabad, Telangana, India | |||
| Ayuurleiutis Solutions Private Limited | ₹73,066 (FY 2025) | -66.0% | Nagaur, Rajasthan, India | |||
| Skyline Biotech Private Limited | ₹71,875 (FY 2025) | Sangli, Maharashtra, India | ||||
| Allianz Biotech Private Limitedthis company | ₹71,198 (FY 2024) | ₹33,780 | 47.4% | 82.0% | Chennai, Tamil Nadu, India | |
| Balusu Pharma Private Limited | ₹71,054 (FY 2023) | 166.0% | Hyderabad, Telangana, India | |||
| Kismat Medi Care Private Limited | ₹71,000 (FY 2025) | 1075.0% | Bharuch, Gujarat, India | |||
| Aulea Healthcare Private Limited | ₹70,835 (FY 2024) | -75.0% | Southwestdelhi, Delhi, India | |||
| Sunway Life Sciences Private Limited | ₹70,620 (FY 2025) | 21.0% | Hyderabad, Telangana, India | |||
| Swa-Jay Health Care Formulations India Private Limited | ₹70,000 (FY 2025) | Dadri, Uttar Pradesh, India |
To see the full peer comparison of Allianz Biotech Private Limited, buy the company report.
Auditor
Allianz Biotech Private Limited is audited by M C RANGANATHAN & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M C RANGANATHAN & CO | FY 2019 | 003061S |
Shareholding
The shareholding of Allianz Biotech Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Allianz Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Allianz Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Allianz Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Allianz Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Allianz Biotech Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Kishor Lal Daga ceased to be Director on 29 Mar 2019.
Frequently asked questions
Allianz Biotech has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Allianz Biotech was a private limited company based in Chennai, Tamil Nadu, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 08 September 2003 and is registered under CIN U24231TN2003PTC051535. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Allianz Biotech was incorporated on 08 September 2003. It is registered with the Registrar of Companies, Chennai.
Allianz Biotech had 2 directors:
- Bhawarlal Gour - Director
- Radha Kishan Jhaver - Director
The CIN (Corporate Identification Number) of Allianz Biotech is U24231TN2003PTC051535. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Allianz Biotech is at Unit No.9B 3rd Floor R A Building 72 Marshalls Road Egmore, Chennai, Tamil Nadu, India – 600008.
The latest financial statements of Allianz Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 14 August 2024. Year-wise statements from 2015 are in the company report.
Allianz Biotech operated in the pharma industry, in the drug formulation and development segment.
The peers of Allianz Biotech by revenue are Open Source Pharma Foundation, Albay Pharmaceuticals Private Limited, Cronus Research Labs Private Limited, Ayuurleiutis Solutions Private Limited, Skyline Biotech Private Limited and 5 more, all in the Pharma industry (Formulations).
Kishor Lal Daga ceased to be Director on 29 Mar 2019. Bhawarlal Gour ceased to be Additional Director on 25 Sep 2018. Abhishek Sewag ceased to be Director on 29 Jun 2018. Allianz Biotech has 6 board changes on record in total.
The compliance status of Allianz Biotech is compliant as of 28 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
